Donaldson Company strengthens presence in biopharma with Solaris Biotechnology acquisition
Donaldson Company, Inc., a global provider of filtration products and solutions, has acquired Solaris Biotechnology Srl for around €41m ($46m).
Archives for November 23, 2021
AstraZeneca opens new advanced therapeutics R&D facility in Cambridge
AstraZeneca has built a new R&D facility - The Discovery Centre (DISC) - in Cambridge in the UK.
Vaccibody becomes Nykode Therapeutics, teams up with Regeneron on cancer vaccines
Vaccibody, a Norway-based pioneer in the neoantigen cancer vaccine space, has changed its name to Nykode Therapeutics, and has entered into a license and collaboration agreement with US company, Regeneron, to develop vaccines against cancer and...
CEPI to expand COVID-19 vaccine testing network to other epidemic and pandemic threats
A centralized testing approach, developed by the Coalition for Epidemic Preparedness Innovations (CEPI) and used by more than 30 COVID-19 vaccine developers, will be expanded to create a standardized evaluation model for other epidemic and pandemic...